Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02276885 · ClinicalTrials.gov registry record · NA
Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial
A NA study of Breast Cancer, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 284
- Enrollment target
- 1
- Study location
NCT02276885 is a NA study of Breast Cancer that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 284 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02276885, a NA study of Breast Cancer, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 284 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test whether a radiotherapy regimen of 8 GY x 3 days over 5 days (every other day) is as safe (well-tolerated) and effective as 6 Gy x 5 over five consecutive days
Conditions Studied
Interventions
- RADIATION PBI Radiotherapy 6 Gy
- RADIATION PBI Radiotherapy 8 Gy
Study Locations (1)
New York
- NYU Langone Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 284 participants |
| Start Date | 2014-10-28 |
| Est. Completion | 2026-12-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02276885
The ClinicalTrials.gov registry entry for NCT02276885 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 284 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (90% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which PBI Radiotherapy 6 Gy is the first listed.
NCT02276885 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02276885 about?
NCT02276885 is a clinical study titled "Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial". The purpose of this study is to test whether a radiotherapy regimen of 8 GY x 3 days over 5 days (every other day) is as safe (well-tolerated) and effective as 6 Gy x 5 over five consecutive days
What is the current status of trial NCT02276885?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 284 participants. The study started on 2014-10-28. Estimated completion is 2026-12-07.
What conditions does trial NCT02276885 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT02276885?
The interventions under investigation include: PBI Radiotherapy 6 Gy (RADIATION), PBI Radiotherapy 8 Gy (RADIATION).
Who is sponsoring clinical trial NCT02276885?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02276885 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.